“…Interestingly, many of the studies investigating the pathogenic effects of arsenic exposure use concentrations of arsenite in the >5 µM micromolar range [375–750 ppb As(III)], reflecting concentrations that might be observed only in the most severely affected areas. Many of the observed effects in this range, such as increased reactive oxygen species (ROS) production (Alarifi et al ., 2013; Jiang et al ., 2013; Kumar et al ., 2014), DNA damage (Andrew et al ., 2006; Hughes et al ., 2011; Prakash et al ., 2016), mitochondrial dysfunction (Liu et al ., 2005), glutathione depletion (Li and Chen, 2016), and protein modifications (Shen et al ., 2013), might not occur at lower, more relevant concentrations. Furthermore, the compound, cell type, and time of treatment matters, with As 2 O 3 exhibiting a more consistent increase in ROS production at acute time points (Barchowsky et al ., 1999; Yen et al ., 2012; Lu et al ., 2014), whereas chronic NaAsO 2 treatment (i.e.…”